Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Claimed Company
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions read more
I have only been with Karyopharm for less than 3 months, but I am very happy with my decision to join the team!
What is most positive about the culture and environment at your company?
The excitement associated with the expanded use of XPOVIO.
What makes you most happy at work?
Meeting the needs of the teams that I support. Trying to help them be more efficient.
Other Employee Reviews for Karyopharm Therapeutics
×